Depigmented and Polymerised Allergenic Extract of Dermatophagoides Pteronyssinus [house dust mite allergy vaccine] as Antiasthmatic Treatment for Children With Slight Allergic Asthma to Mites.

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 10 Mar 2019

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs House dust mite allergy immunotherapy Laboratorios LETI (Primary) ; House dust mite allergy immunotherapy Laboratorios LETI (Primary)
Indications Allergic asthma
Focus Therapeutic Use

01 Mar 2019 Status changed from suspended to discontinued.
27 Jan 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
05 Mar 2008 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com